BMJ4d
Update of EULAR recommendations for the treatment of systemic sclerosis
The aim was to update the 2009 European League against Rheumatism (EULAR) recommendations for the treatment of systemic sclerosis (SSc), with attention to new therapeutic questions. Update of the ...
BMJ2d
2019 update of the EULAR recommendations for the management of systemic lupus erythematosus
Correspondence to Dr Antonis Fanouriakis, Rheumatology and Clinical Immunology Unit, “Attikon” University Hospital, Athens 12462, Greece; afanour{at}med.uoa.gr Our objective was to update the EULAR ...
BMJ2d
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
Correspondence to Dr Dimitrios T Boumpas, Rheumatology and Clinical Immunology Unit, 4th Department of Internal Medicine, "Attikon" University Hospital, Joint Academic Rheumatology Program, National ...
BMJ2d
Withdrawal of low-dose prednisone in SLE patients with a clinically quiescent disease for more than 1 year: a randomised clinical trial
1 Sorbonne Université, Assistance Publique–Hôpitaux de Paris, Groupement Hospitalier Pitié–Salpêtrière, French National Referral Center for Systemic Lupus Erythematosus, Antiphospholipid Antibody ...
BMJ2d
Health status of patients with ankylosing spondylitis: a comparison with the general population
Objective: To examine the subjective health in patients with ankylosing spondylitis (AS) compared with the general population, and to explore the associations between health status and age, sex of the ...
BMJ4d
Controlled clinical trial of IV cyclophosphamide versus IV methylprednisolone in severe neurological manifestations in systemic lupus erythematosus
1 Clinical Epidemiology Research Unit, Hospital Especialidades, Centro Médico Nacional Instituto Mexicano del Seguro Social, Mexico 2 Internal Medicine Department, Centro Médico Nacional Instituto ...
BMJ2d
Quality indicators for the primary care of osteoarthritis: a systematic review
Design Systematic review and narrative synthesis. Data sources Electronic reference databases (MEDLINE, EMBASE, CINAHL, HMIC, PsychINFO), quality indicator repositories, subject experts. Eligibility ...
BMJ1d
Interleukin 27 attenuates collagen-induced arthritis
Department of Physiology, Yong Loo Lin School of Medicine, University of Singapore, Singapore Professor F Y Liew, Division of Immunology, Infection and Inflammation, Glasgow Biomedical Research Centre ...
BMJ4d
Potential relationship between herpes viruses and rheumatoid arthritis: analysis with quantitative real time polymerase chain reaction
Objective: To determine whether the human herpes viruses, cytomegalovirus (CMV), Epstein-Barr virus (EBV), and human herpesvirus 6 (HHV-6), are detectable in serum and peripheral blood mononuclear ...
BMJ6d
Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis
Dr T Yamada, Department of Clinical Pathology, Juntendo University School of Medicine, 2–1–1 Hongo, Bunkyo-ku, Tokyo, 113–8421 Japantoshiyam{at}med.juntendo.ac.jp OBJECTIVES (1) To determine whether ...
BMJ4d
FRI0582 Fluctuating Levels of Rheumatoid Factor Predict Progression of Rheumatoid Arthritis, but Not Independent of Disease Activity
Background The presence of rheumatoid factor (RF) is associated with progression of joint damage in patients with rheumatoid arthritis (RA). RF levels may change during the course of therapy 1, but it ...
BMJ6d
Effects of ibuprofen on molecular markers of cartilage and synovium turnover in patients with knee osteoarthritis
Objective: The aim of this study was to evaluate the effect of ibuprofen on the urinary excretion of C-terminal crosslinking telopeptide of type II collagen (CTX-II) and urinary glucosyl galactosyl ...